Stichworte
Schizophrenie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

259 Suchergebnisse.

Sortieren (Relevanz) ▾

Eligibility Schizophrenia NCT02142556

- 26.10.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT02142556

Eligibility Schizophrenia NCT01894984

- 26.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01894984

Eligibility Schizophrenia NCT01812642

- 26.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01812642

Eligibility Schizophrenia NCT01724359

- 26.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01724359

Eligibility Schizophrenia NCT01662648

- 26.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01662648

Eligibility Schizophrenia NCT01615185

- 26.10.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01615185

Eligibility Schizophrenia NCT01606254

- 25.10.18 - 1 Formular, 1 Itemgruppe, 10 Datenelemente, 1 Sprache
Itemgruppe: Inclusion Criteria
A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01606254

Eligibility Schizophrenia NCT01606228

- 25.10.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01606228

Eligibility Schizophrenia NCT01577160

- 25.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01577160

Eligibility Schizophrenia NCT01541371

- 25.10.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01541371

Eligibility Schizophrenia NCT01401491

- 25.10.18 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine; ODM derived from: https://clinicaltrials.gov/show/NCT01401491

Eligibility Schizophrenia NCT01391403

- 24.10.18 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01391403